Wockhardt jumps on receiving USFDA’s final approval for Alfuzosin hydrochloride tablets

14 Aug 2012 Evaluate

Wockhardt is currently trading at Rs. 1237.10, up by 37.85 points or 3.16% from its previous closing of Rs. 1199.25 on the BSE.

The scrip opened at Rs. 1195.00 and has touched a high and low of Rs. 1243.95 and Rs. 1188.10 respectively. So far 205067 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1243.95 on 14-Aug-2012 and a 52 week low of Rs. 251.25 on 06-Jan-2012.

Last one week high and low of the scrip stood at Rs. 1243.95 and Rs. 1073.00 respectively. The current market cap of the company is Rs. 13524.64 crore.

The promoters holding in the company stood at 73.64% while Institutions and Non-Institutions held 8.86% and 17.32% respectively.

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 10mg extended release tablets of Alfuzosin hydrochloride, which is used in treatment of Benign Prostatic Hyperplasia or enlarged prostate. Alfuzosin is the generic name for the brand Uroxatral, marketed in the United States by Sanofi-Aventis. The company would be launching this product immediately.

According to IMS Health, the total market for this product in the US is about $81.5 million. Wockhardt will be manufacturing Alfuzosin hydrochloride API in its facility at Ankleshwar, India and the extended release tablets of Alfuzosin at its facility in Aurangabad, India. The technology for the API and the capsules were developed in-house.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s , the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.


 

Wockhardt Share Price

1230.95 58.60 (5.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.